Paper Review Records
All Paper Review Records
2 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Human spiroplasmosis: Clinical characterisation of a newly recognised tick-associated febrile illness
Petra Bogovič; Miša Korva; Andrej Kastrin; Nataša Knap; Rok Kogoj; Katarina Resman Rus; Tatjana Avšič-Županc; Miroslav Petrovec; Franc StrleShow moreShow less
Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia; Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; Institute for Biostatistics and Medical Informatics, Faculty of Medicine, University of Ljubljana, Ljubljana, SloveniaShow moreShow less
Dose-dependent efficacy of intravenous brincidofovir across adenovirus species in immunocompromised patients
Chantal Lucini; Nkechie Azie; Sunando Roy; Helena Tutill; Rachel Williams; Judith Breuer; Sandra Preuner; Lisa Grösslinger; Thomas LionShow moreShow less
St. Anna Children´s Cancer Research Institute (CCRI), Zimmermannplatz 10, 1090 Vienna, Austria; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Währinger Gürtel 18–20, 1090 Vienna, Austria; SymBio Pharma USA, Inc., Durham, North Carolina, USA; Genetics and Genomic Medicine Department, University College London (UCL) Great Ormond Street Institute of Child Health, 30 Guilford Street London, London WC1N 1EH, UK; Infection, Immunity & Inflammation Department, UCL Great Ormond Street Institute of Child Health, 30 Guilford Street London, London WC1N 1EH, UK; Labdia Labordiagnostik, Zimmermannplatz 8, 1090 Vienna, Austria; Department of Pediatrics, Medical University of Vienna, Währinger Gürtel 18–20, 1090 Vienna, AustriaShow moreShow less
FAQ
How long does JOURNAL OF INFECTION take to review a manuscript?
As of 2026-11-19, CrushSCI has 2 complete review records for JOURNAL OF INFECTION. The fastest paper went from submission to acceptance in 65 days (Dose-dependent efficacy of intravenous brincidofovir across adenovirus species in immunocompromised patients, received 2026-06-12, accepted 2026-08-16); the slowest took 94 days. The average is 79.5 days and the median is 79.5 days. With fewer than 5 records, treat this as indicative only.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
